The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This study is designed to explore the effect of increased and decreased urinary pH on the
single pharmacokinetic (PK) dose of LY2140023 and its active metabolite LY404039. All
participants will receive the three treatments in a randomized order.